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One of the deadly complication of acute myocardial infarction is left ventricular free wall/ventricular septal rupture, which occurred in 4-24% in necropsy patients with fatal MI before the 7 widespread use of cardiac care units. Among the survivors of acute myocardial infarctions, 1-2% developed this devastating complication in the pre- [8] [9] [10] thrombolytic era. This incidence has reduced to a figure of 0.4% in the thrombolytic era as shown by the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial, which studied 41,021 patients at 11, 12 1081 sites in 15 different countries. This is further reduced to 0.17% in APEX-MI registry, with improvement in pharmaco-invasive therapy being the 13, 14 reason for this drastic reduction. Similarly, Moreyra AE, et al. in 2010 found incidence of acquired VSR as 0.2% from Microbial Database for Activated Sludge (MiDAS) database in 15 New Jersey, USA.
It usually occurs in the first week after MI, with a mean time from symptom onset of 3 to 5 days. GUSTO Investigators showed that risk factors most associated with this complication were advanced age, anterior infarction, female sex and 11 no previous smoking. VSR has extremely poor outcomes, particularly in untreated cases where 16 mortality is 94 percent at 30 days. The transcatheter closure of post-MI VSR has a success rate of 89% (95% CI 84% -93%) as reported by the meta-analysis 16 reported by De Puy, et al.
The aim of this study is to determine the incidence of ventricular septal rupture after acute myocardial infarction and to identify cardiovascular risk factors and clinical parameters with the mortality in these patients once this complication occurred. By determining this information in our region where it is not known till now, we will be able to find out the cases which need early intervention for correction that will definitely reduce the mortality from acquired VSR.
METHODS
This is a retrospective study done at Cardiology department of Lady Reading Hospital, Pakistan. In this study record of 6240 patients with acute MI admitted over a period of three years between January, 2014 and December, 2016 were analyzed.
Record of included patients was from either gender, having AMI complicated by VSR which were confirmed by transthoracic echocardiography. Patients were grouped on the basis of their outcomes, whether they survived (discharged/reffered) or died during hospital stay. Those patients who were previously diagnosed as having VSD, cerebro-vascular accident, recent trauma or major surgery, severe mitral regurgitation, free wall rupture, or heart block were excluded.
Record regarding (blood pressure, heart rate and Killip class) and renal profile were recorded at the time of VSR diagnosis.
All cases underwent a comprehensive echocardiography examination that included M-Mode, 2 Dimensional and Doppler (continuous wave and color) with Toshiba machine by an experienced cardiac sonographer at a time of development of acquired VSR. Number and location of defects, direction and severity of shunt and effect of VSR on cardiac chambers sizes and function were studied in detail.
The data was entered into SPSS version 20. Normally distributed continuous variables like age, systolic and diastolic BP, heart rate, creatinine and random blood sugar were expressed as mean± standard deviation. Frequency and percentages were used for categorical variables like gender, hypertension (HTN), diabetes mellitus (DM), smoking, previous MI, Killip class, number of VSR and outcome. Correlation of cardiovascular risk factors and different clinical parameters with the mortality was assessed with the chi-square test.
A total of 6240 patients with acute myocardial infarction data were analyzed in which 60 patients developed ventricular septal rupture. Twenty six patients were excluded due to presence of other concomitant complications (Figure 1) . It showed an incidence of acquired VSR which is 0.96%, with acute anterior MI having 64.7% among them.
A data of rest 34 patients was studied in detail. Mean age of post-MI VSR patients was 63.21±8.9 years, with 52.9% were male patients. Mean time of development of VSR was 4.1±2.2 days with the minimum of one day and maximum of 10 days after diagnosis of acute MI. Nineteen patients (55.9%) didn't receive streptokinase (either late for it or there was significant contraindication for it). About 38.2% of patients of total VSR died. Rest were either discharged on medical therapy or referred for closure. Cardiovascular risk factors and clinical features of these patients are shown in Table I . Table II shows chi-square correlation of different baseline characteristics with the outcomes in post-MI VSR patients. Figure 2 shows mortality in various CV risk factors and clinical parameter groups. It shows higher mortality in patients with negative history of CV risk factors except for diabetes, anterior MI, multiple VSRs, no thrombolytics, having shock and renal impairment. Figure 3 shows time of death in these patients after development of VSR. It shows that number of deaths increases with time if patient were not referred for closure.
RESULTS

POST MYOCARDIAL INFARCTION VENTRICULAR SEPTAL RUPTURE AND FACTORS ASSOCIATED WITH ITS MORTALITY: A RETROSPECTIVE STUDY
VSR is one of the rare complications of acute myocardial infarction but carries a very high mortality rate. Its incidence in our study is 0.96% which is quite lower DISCUSSION than pre-thrombolytic era. However, it is higher than GUSTO-1 trial where it was 0.2%. This may be explained by two factors. First, all patients in GUSTO-1 trial received thrombolytics and secondly, they were thrombolyzed 12 within 6 hours. The mean time of development of VSR after AMI is 4.1±2.2 days which is longer than 17, 18 Becker RC, et al. study.
The mortality in our study was 38.2%, which is almost half of Crenshaw BS, et 19 al. study i.e. 74%. The reason for this may be that the patients who were discharged or referred were not followed. Secondly, the VSR patients may have died before echo. Lastly, the sample size was small. increased to 8.5 times in our study.
It is certainly true that thrombolytics reduced the incidence of VSR development. However, once this complication occur, then history of streptokinase taken is no more significant in determining the outcome 20, 21 of these patients. Late administration of thrombolytic therapy also appears to improve survival but may increase the 21 risk of cardiac rupture.
The limitations of the study are that it is a retrospective study in which data from software were retrieved which had some missing data. Secondly, number of patients with VSR was very small. Third, follow up data of these patients was not available as many survivors of it were referred to other units. Lastly, patients with concomitant presence of other complications like severe mitral regurgitation and heart block patients were also excluded which would have definitely reduced the true mortality from VSR.
VSR incidence after AMI in our study was 0.96% with 8.5 times greater in first-MI and have a delayed onset. Diabetes mellitus, multiple lesions, presence of shock, tachycardia, renal impairment and high Killip class after development of VSR are associated with high mortality.
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CONCLUSIONS
